C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2002
11/07/2002	US20020165374 Secreted protein HFEAF41
11/07/2002	US20020165373 Contacting the sample with an isolated recombinant immunodominant Neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex
11/07/2002	US20020165371 Compositions and methods for the therapy and diagnosis of breast cancer
11/07/2002	US20020165367 Separation of glycosylated and nonglycosylated proteins; generate matrix with immobilized triazine dye, incubate with protein mix, wash, elute proteins, recover preferential proteins
11/07/2002	US20020165366 Method for purifying FSH
11/07/2002	US20020165365 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same
11/07/2002	US20020165364 Fluorescent indicator for use as tool in genetic engineerging
11/07/2002	US20020165363 Cachexia remedy
11/07/2002	US20020165361 Antibody for use in the diagnosis and treatment of cell proliferation disorders
11/07/2002	US20020165359 Gelatin for use in the generation of films on capsules
11/07/2002	US20020165358 Tumor cytotoxic factor for use in the treatment of cell proliferative and liver disorders
11/07/2002	US20020165357 38554, 57301 and 58324, human organic ion transporters and uses therefor
11/07/2002	US20020165356 Zinc finger binding domains for nucleotide sequence ANN
11/07/2002	US20020165355 Methylated, SmD homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
11/07/2002	US20020165354 Nucleotide sequences coding polypeptides for use in the treatment of septic shock, cachexia, graft-versus host, autoimmune and rheumatic diseases
11/07/2002	US20020165353 Transport protein for use in human therapeutics and diagnostics
11/07/2002	US20020165352 Protein complex for use in the diagnosis and treatment of diabetes and nervous system disorders
11/07/2002	US20020165351 Novel compounds
11/07/2002	US20020165350 Novel polypeptide, a method of producing it, and utility of the polypeptide
11/07/2002	US20020165349 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system disorder and alzheimer's disease
11/07/2002	US20020165348 Human cytokine receptor
11/07/2002	US20020165347 Polypeptide for use in the diagnosis, prevention and treatment of arteriosclerosis and vascular restenosis
11/07/2002	US20020165346 Isolated mammalian membrane protein genes; related reagents
11/07/2002	US20020165345 Prostate cancer gene
11/07/2002	US20020165344 Bacterial mutant for generating bacterial toxins for use in developing vaccine against infections
11/07/2002	US20020165342 Glucagon-like insulinotropic peptides, compositions and methods
11/07/2002	US20020165265 Microtubule disrupter such as paclitaxel, and a polymeric carrier that is NOT a capsule; embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions
11/07/2002	US20020165194 Method for selective inactivation of viral replication
11/07/2002	US20020165193 Compositions and methods of treating tumors
11/07/2002	US20020165191 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
11/07/2002	US20020165190 Expression vector coding p972 gene for cancer therapy and adenovirus producing the same
11/07/2002	US20020165188 Methods for inhibition of tumorigenic properties of melanoma cells
11/07/2002	US20020165186 Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/07/2002	US20020165185 Novel Heparin-induced CCN-like molecules and uses therefor
11/07/2002	US20020165182 Gene encoding Protein Cluster I and the encoded protein
11/07/2002	US20020165177 Modified factor VIII cDNA
11/07/2002	US20020165176 Sequences encoding an influenza virus M2 antigen, wherein said nucleic acid sequence is not present in a recombinant viral vector; DNA vaccines
11/07/2002	US20020165172 Compositions and methods for treating intracellular diseases
11/07/2002	US20020165163 Inhibits the binding of tumor necrosis factor(TNF) to its receptors, and the cytotoxic effect of TNF; non-proteolytic protein isolated from human urine, of given amino acid sequence
11/07/2002	US20020165162 Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
11/07/2002	US20020165161 Chemokine-binding proteins for treating congestive heart failure
11/07/2002	US20020165160 Fibroblast growth factor (FGF) mutein; treating coronary artery disease (atherosclerosis)
11/07/2002	US20020165159 Administering a luteinizing hormone releasing hormone antagonist or agonist peptide to selectively change the amount of follicle- stimulating hormone (FSH) in blood to control fertility
11/07/2002	US20020165157 Involved in apoptosis
11/07/2002	US20020165156 Tumor necrosis factor family and its blocking agent
11/07/2002	US20020165155 Crystallization of IGF-1
11/07/2002	US20020165154 Lipoprotein-regulating medicaments
11/07/2002	US20020165153 DNA binding domain of a basic domain and an adjacent leucine zipper domain
11/07/2002	US20020165151 Promoting smooth muscle cell growth or vasculogenesis with an antibody that reacts with the protein
11/07/2002	US20020165150 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors
11/07/2002	US20020165149 Mutated class II major histocompatibility proteins
11/07/2002	US20020165148 Analogues and derivatives of gastrin releasing peptide (GRP)
11/07/2002	US20020165147 Treating seizures or epilepsy
11/07/2002	US20020165146 Follicle stimulating hormone (FSH) products used in the treatment of infertility
11/07/2002	US20020165145 Encode Rho GEF protein members
11/07/2002	US20020165144 Neuregulin 1 gene (NRG1) and polypeptides
11/07/2002	US20020165143 Identification and isolation of novel DNA
11/07/2002	US20020165142 DAZ genes
11/07/2002	US20020165140 Screening methods
11/07/2002	US20020165139 Construction of a structural variant of sublancin to facilitate its isolation and use in bioremediation of environmental contamination by gram-positive spore formers such as Bacillus anthrasis
11/07/2002	US20020165138 Compositions and methods for the treatment of sepsis
11/07/2002	US20020165137 Diagnosing, treating, preventing and/or prognosing disorders related to these polypeptides
11/07/2002	US20020165136 Induction of apoptosis of cancer cells using major histocompatibility complex class I peptides
11/07/2002	US20020165135 Compositions and methods related to canine IgG and canine IL-13 receptors
11/07/2002	US20020165132 Lanthionine bridged peptides
11/07/2002	US20020165131 Histidine-rich glycoprotein
11/07/2002	US20020165129 Peptides and their use to ameliorate cell death
11/07/2002	US20020165128 Compositions and methods for proteolytically inactivating infectious agents using lactoferrin and related molecules
11/07/2002	US20020165123 CXCR4 agonist treatment of hemapoietic cells
11/07/2002	US20020164962 Apparatuses, methods, and computer programs for displaying information on mobile units, with reporting by, and control of, such units
11/07/2002	US20020164803 Nucleotide sequences for use as transformation tools in genetic engineering
11/07/2002	US20020164801 Human and mammalian DNA replication origin consensus sequences
11/07/2002	US20020164799 Expression vector coding proteins for use in the treatment of cancer
11/07/2002	US20020164792 Identification of human cell lines for the production of human proteins by endogenous gene activation
11/07/2002	US20020164789 Suppressing glial cell activation in central nervous system; obtain mammal with brain disorder, administer modulator of nervous system activity, evaluate for adjusstment in brain disorder
11/07/2002	US20020164785 Nucleotide sequences coding membrane protein for use in the detecting ligand receptors
11/07/2002	US20020164784 Novel human 7TM proteins and polynucleotides encoding the same
11/07/2002	US20020164783 Nucleotide sequences coding polypeptide for use in the treatment of hereditary respiratory system disorders
11/07/2002	US20020164772 Multiple drug resistance gene atrD of aspergillus nidulans
11/07/2002	US20020164770 DNA transfection system for the generation of infectious influenza virus
11/07/2002	US20020164764 Transmembrane polypeptide expressed by lymphocytes
11/07/2002	US20020164763 84241, a novel human ring finger family member and uses thereof
11/07/2002	US20020164761 Nucleotide sequences coding polypeptide for use in the treatment and prevention of bacterial propagation
11/07/2002	US20020164757 Plant proteins
11/07/2002	US20020164756 Nucleotide sequences coding polypeptides for use in screening bactericides
11/07/2002	US20020164753 Enzymatic polypeptide for use as tools in genetic engineering
11/07/2002	US20020164747 Gene cluster for ramoplanin biosynthesis
11/07/2002	US20020164740 Polypeptide for use in diagnosis and treatment of brain and epileptic disorders
11/07/2002	US20020164739 Protein for use in the diagnosis and treatment of osteoarthritis
11/07/2002	US20020164738 Cell death inhibitory protein
11/07/2002	US20020164735 Methods and compositions relating to a cardiac-specific nuclear regulatory factor
11/07/2002	US20020164734 Human pelota homolog
11/07/2002	US20020164732 Polypeptide for use in the treatment and prevention of viral infection
11/07/2002	US20020164721 Design of a polyepitopic construct for the induction of HLA-A2.1 restricted HIV 1 specific CTL responses using HHD mice
11/07/2002	US20020164719 Targeting pharmaceutical agents to injured tissues
11/07/2002	US20020164718 Metal ion affinity tags and methods for usig the same
11/07/2002	US20020164716 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding
11/07/2002	US20020164715 Nucleotide seqences coding polypeptides for use in the treatment and diagnosis of cancer
11/07/2002	US20020164714 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders
11/07/2002	US20020164713 Nucleotide seqqquences coding polypeptide for use in the treatment and prevention of cancer, liver and urogenital disorders

1 ... 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 ... 2916